153 related articles for article (PubMed ID: 16181349)
1. Immunity markers in patients with Helicobacter pylori infection: effect of eradication.
Dore MP; Fastame L; Tocco A; Negrini R; Delitala G; Realdi G
Helicobacter; 2005 Oct; 10(5):391-7. PubMed ID: 16181349
[TBL] [Abstract][Full Text] [Related]
2. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
3. Long-term re-infection rate after Helicobacter pylori eradication in Bangladeshi adults.
Ahmad MM; Ahmed DS; Rowshon AH; Dhar SC; Rahman M; Hasan M; Beglinger C; Gyr N; Khan AK
Digestion; 2007; 75(4):173-6. PubMed ID: 17700024
[TBL] [Abstract][Full Text] [Related]
4. Impaired host immunity contributes to Helicobacter pylori eradication failure.
Borody T; Ren Z; Pang G; Clancy R
Am J Gastroenterol; 2002 Dec; 97(12):3032-7. PubMed ID: 12492186
[TBL] [Abstract][Full Text] [Related]
5. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
Katsinelos P; Tziomalos K; Chatzimavroudis G; Vasiliadis T; Katsinelos T; Pilpilidis I; Triantafillidis I; Paroutoglou G; Papaziogas B
Med Princ Pract; 2007; 16(2):119-23. PubMed ID: 17303947
[TBL] [Abstract][Full Text] [Related]
6. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
7. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies.
Scandellari R; Allemand E; Vettore S; Plebani M; Randi ML; Fabris F
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):108-13. PubMed ID: 19786938
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxin associated gene A-positive Helicobacter pylori strains in dyspeptic pregnant women.
Noyan V; Apan TZ; Yucel A; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):186-9. PubMed ID: 15358462
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
10. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test.
Magen E; Mishal J; Schlesinger M; Scharf S
Helicobacter; 2007 Oct; 12(5):567-71. PubMed ID: 17760727
[TBL] [Abstract][Full Text] [Related]
11. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever.
Ozel AM; Demirturk L; Aydogdu A; Gultepe M; Yazgan Y; Imirzalioglu N; Gurbuz AK; Narin Y
Int J Clin Pract; 2008 May; 62(5):754-61. PubMed ID: 17343670
[TBL] [Abstract][Full Text] [Related]
12. Organ-specific autoantibodies in children with Helicobacter pylori infection.
Guariso G; Brotto F; Basso D; Alaggio R; Betterle C
Helicobacter; 2004 Dec; 9(6):622-8. PubMed ID: 15610075
[TBL] [Abstract][Full Text] [Related]
13. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
[TBL] [Abstract][Full Text] [Related]
14. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.
Hokkanen S; Kosunen TU; Sarna S; Miettinen A; Salomaa A; Aromaa A; Knekt P; Rautelin HI
Scand J Clin Lab Invest; 2005; 65(4):291-9. PubMed ID: 16076684
[TBL] [Abstract][Full Text] [Related]
15. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
Tan HJ; Rizal AM; Rosmadi MY; Goh KL
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821
[TBL] [Abstract][Full Text] [Related]
16. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura.
Kodama M; Kitadai Y; Ito M; Kai H; Masuda H; Tanaka S; Yoshihara M; Fujimura K; Chayama K
Helicobacter; 2007 Feb; 12(1):36-42. PubMed ID: 17241299
[TBL] [Abstract][Full Text] [Related]
17. [Genetic type of Helicobacter pylori and the efficacy of eradication therapy].
Parzecka M; Szaflarska-Popławska A; Mierzwa G; Gorzkiewicz M; Łuczak S; Grzybowski T
Pol Merkur Lekarski; 2009 Feb; 26(152):105-9. PubMed ID: 19388513
[TBL] [Abstract][Full Text] [Related]
18. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
[TBL] [Abstract][Full Text] [Related]
20. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
